The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $137.14

Today's change-4.52 -3.19%
Updated July 28 4:02 PM EDT. Delayed by at least 15 minutes.
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $137.14

Today's change-4.52 -3.19%
Updated July 28 4:02 PM EDT. Delayed by at least 15 minutes.

USANA Health Sciences Inc down (U.S.)$4.52

USANA Health Sciences Inc closed sharply lower Thursday, dropping (U.S.)$4.52 or 3.19% to (U.S.)$137.14. Over the last five days, shares have gained 9.77% and 7.35% year to date. Shares have outperformed the S&P 500 by 5.41% during the last year.

Key company metrics

  • Open(U.S.) $139.37
  • Previous close(U.S.) $141.66
  • High(U.S.) $139.40
  • Low(U.S.) $134.61
  • Bid / Ask(U.S.) $111.11 / (U.S.) $0.00
  • YTD % change+7.35%
  • Volume194,231
  • Average volume (10-day)110,372
  • Average volume (1-month)100,519
  • Average volume (3-month)105,211
  • 52-week range(U.S.) $92.00 to (U.S.) $176.88
  • Beta1.18
  • Trailing P/E18.41×
  • P/E 1 year forward17.69×
  • Forward PEG1.77×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $7.45
Updated July 28 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.35%

Based on its net profit margin of 10.35%, USANA Health Sciences Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.04%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 02, 201604/02/2016Jan 02, 201601/02/2016Oct 03, 201510/03/2015Jul 04, 201507/04/2015
Revenue240233233233
Total other revenue--------
Total revenue240233233233
Gross profit198192192193
Total cost of revenue43404140
Total operating expense207197195194
Selling / general / administrative164157154154
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income34353839
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax33363839
Income after tax22242625
Income tax, total11121313
Net income22242625
Total adjustments to net income--------
Net income before extra. items22242625
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items22242625
Inc. avail. to common incl. extra. items22242625
Diluted net income22242625
Dilution adjustment------0
Diluted weighted average shares13131313
Diluted EPS excluding extraordinary itemsvalue per share1.771.831.921.92
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share1.771.831.921.92